
Beyond smoking: debunking lung cancer myths and the case for broader screening
Lung cancer is not solely a smoker’s disease, with up to a quarter of cases occurring in never-smokers and risk shaped by environment, genetics, and race. While low-dose CT screening can reduce mortality, current guidelines tied to a 20-pack-year history miss many at risk, prompting NCCN and ACS to broaden criteria and programs like INSPIRE to reach more Black patients and others outside traditional thresholds. New AI tools (e.g., Sybil) show potential to predict cancer risk from a single CT and personalize screening intervals, signaling a shift toward risk-based, more inclusive screening and earlier detection to reduce disparities.












